Robotic-assisted Surgery Systems Market by Components (Instruments & Accessories, Services, Systems), Applications (Cardiothoracic, ENT, General Surgery), End Users - Global Forecast 2025-2032
Description
The Robotic-assisted Surgery Systems Market was valued at USD 9.62 billion in 2024 and is projected to grow to USD 11.27 billion in 2025, with a CAGR of 18.94%, reaching USD 38.57 billion by 2032.
A concise orientation to how technological maturation, clinical validation, and service ecosystems are driving strategic adoption of robotic-assisted surgical platforms
Robotic-assisted surgery systems have evolved from a nascent surgical aid into a platform technology reshaping clinical pathways across multiple surgical specialties. Over the past decade, technological refinements in robotic arms, endoscopic visualization, and instrument ergonomics have converged with expanding clinical evidence to drive broader adoption among hospitals, specialty clinics, and ambulatory surgical centers. As a result, stakeholder expectations have shifted from proof-of-concept demonstrations toward demonstrated improvements in workflow efficiency, perioperative outcomes, and patient throughput.
Consequently, the competitive dynamic now favors integrated solutions that combine flexible hardware architectures with modular instruments and a clear services strategy encompassing training and maintenance. Investors and healthcare executives are increasingly focused on interoperability with digital health records, analytics-enabled performance monitoring, and scalable service models that reduce total cost of ownership. With these forces in play, strategic decision-makers must balance capital deployment, clinical validation timelines, and long-term service commitments when evaluating robotic platforms for acquisition or partnership.
How modular hardware, expanding clinical applications, and data-driven service models are collectively reshaping vendor differentiation and hospital adoption dynamics
The landscape of robotic-assisted surgery is experiencing transformative shifts driven by three interrelated trends: platform modularity, therapeutic breadth expansion, and digitally enabled services. First, modular hardware architectures and instrument standardization are reducing entry barriers for hospitals and clinics by offering more configurable systems that can be tailored to specialty-specific workflows, thereby enhancing affordability and clinical fit. Second, the clinical application set is expanding beyond early adopters in urology and gynecology into complex domains such as thoracic procedures and orthopedics, reflecting a maturation of surgeon experience and evidence supporting procedural benefits.
Third, the integration of data-driven services-ranging from remote proctoring and training to predictive maintenance-has redefined vendor-customer relationships. These services not only enhance uptime and clinical confidence but also create recurring revenue streams that align vendor incentives with clinical outcomes. Taken together, these shifts are accelerating platform differentiation through software-enabled capabilities and creating a new emphasis on surgical ecosystems where instruments, services, and systems co-evolve to meet institutional priorities.
Practical implications of 2025 tariff measures on sourcing strategies, service logistics, and the total cost dynamics of robotic-assisted surgery platforms
Recent tariff policies introduced in 2025 have introduced an additional operating consideration for supply chain planners, procurement teams, and strategic sourcing functions across the surgical robotics value chain. Import duties on certain imported components and finished platforms have altered the relative economics of sourcing, prompting some suppliers to re-evaluate vendor relationships and to consider nearshoring or regional manufacturing to mitigate exposure. As a direct consequence, procurement cycles now incorporate tariff risk assessments alongside quality and delivery metrics, and contract terms increasingly reflect clauses to address levy changes and currency volatility.
Importantly, the cumulative impact of the tariffs extends beyond unit procurement costs to influence after-sales service logistics and spare-parts pricing. Providers that previously relied on centralized spares hubs may now face longer lead times or higher landed costs for replacement instruments and corrective maintenance activities. In response, several system manufacturers and large hospital networks are exploring alternative strategies, including establishing regional parts inventories, increasing preventive maintenance capabilities to reduce corrective interventions, and negotiating longer-term service agreements to stabilize total cost of ownership. These adaptive measures are reshaping supplier selection criteria and strategic partnerships within the ecosystem.
Segment-specific strategic implications across components, applications, and end-user environments that determine procurement drivers and service priorities
A nuanced understanding of segmentation reveals where clinical demand and commercial opportunity intersect across components, applications, and end-user settings. From a components perspective, the market comprises systems, instruments and accessories, and services; systems now offer choices between single-arm and multi-arm robotic architectures, while instruments and accessories span endoscopic, stapling, and suturing categories, with endoscopic instruments further differentiated into graspers and scissors. The services layer encompasses consultancy, training and education, and maintenance, with maintenance services divided into preventive and corrective modalities, each influencing uptime and lifecycle economics. Together, these component-level distinctions determine purchase rationales, upgrade pathways, and aftermarket revenue potential.
When viewed through the lens of clinical applications, adoption patterns vary across cardiothoracic, ENT, general surgery, gynecology, neurosurgery, orthopedic, and urology procedures, with specialty-specific instrumentation and visualization requirements shaping both capital procurement and consumable replacement rhythms. Simultaneously, the end-user context-whether ambulatory surgical centers, hospitals, or specialty clinics-affects procurement cycles, capital approval processes, and service expectations, since ambulatory settings typically prioritize throughput and cost efficiency whereas tertiary hospitals may emphasize advanced capabilities and training partnerships. Integrating these segmentation dimensions enables more precise targeting of product roadmaps, pricing strategies, and service offerings that align with how different customers deploy and sustain robotic-assisted surgery systems.
How diverse regional regulatory environments, reimbursement landscapes, and manufacturing ecosystems are shaping adoption pathways and commercial strategies globally
Regional dynamics continue to exert a profound influence on clinical adoption, regulatory pathways, and manufacturing strategies. In the Americas, regulatory clarity, reimbursement mechanisms, and strong hospital networks support continued investments in advanced surgical platforms, while supply chain shifts following policy changes are prompting localized sourcing and inventory strategies. Europe, Middle East & Africa presents a heterogeneous picture in which advanced healthcare centers in western Europe drive demand for sophisticated multi-arm platforms and integrated service agreements, whereas markets in other parts of the region prioritize cost-effective systems, targeted training programs, and scalable maintenance solutions to extend clinical reach.
The Asia-Pacific region is characterized by rapid uptake in high-volume surgical centers, growing domestic manufacturing capabilities, and proactive investments in training and infrastructure. Consequently, vendors pursuing a global footprint must adapt commercialization models to regional requirements, balancing centralized engineering excellence with distributed manufacturing and localized service delivery. In each geography, regulatory nuance, reimbursement frameworks, and the structure of hospital procurement processes will continue to shape both adoption velocity and the evolution of partnerships between system providers and healthcare institutions.
Why competitive advantage is shifting from hardware alone to integrated platform ecosystems combining instruments, software, and comprehensive service capabilities
Competitive dynamics in robotic-assisted surgery systems are moving beyond hardware performance to emphasize platform ecosystems that combine durable systems, interoperable instruments, and robust service portfolios. Leading players are investing in instrument modularity, improved haptic feedback, enhanced visualization, and software features that facilitate workflow standardization and analytics-driven performance improvement. Meanwhile, newer entrants are differentiating on price-to-performance ratios, targeted specialty offerings, and partnerships with device suppliers to accelerate instrument availability for niche procedures.
Furthermore, the aftermarket services dimension has emerged as a critical competitive battleground. Firms that can deliver comprehensive training programs, rapid corrective maintenance, and predictive servicing capabilities gain a strategic advantage by increasing customer retention and creating recurring revenue opportunities. Alliances between platform vendors and third-party service providers are becoming more common as companies seek to expand geographic coverage and reduce response times. Ultimately, successful companies will be those that can align clinical evidence, commercial agility, and service excellence to meet the evolving expectations of hospital administrators and surgical teams.
Practical strategic moves for vendors and health systems to capture value through modular design, resilient supply chains, and service-led differentiation
Industry leaders should prioritize a set of actionable initiatives to maintain momentum and capture value as the market evolves. First, invest in modular platform designs that allow for specialty-specific instrument attachments and upgrades without requiring full system replacement, thereby protecting institutional capital investments and enabling phased adoption across departments. Second, develop scalable service models that balance preventive maintenance with remote diagnostics and predictive analytics, reducing downtime while creating recurring revenue streams that align vendor and customer incentives.
Third, strengthen regional manufacturing and parts distribution capabilities to mitigate tariff and logistics risks, while cultivating training partnerships with leading clinical centers to accelerate surgeon proficiency and procedural adoption. Fourth, pursue interoperability and data integration standards that allow platforms to contribute to broader hospital digital strategies, improving clinical workflows and enabling outcome measurement. By implementing these priorities in parallel, organizations can improve customer retention, reduce operational friction, and position their offerings for sustained institutional adoption.
An evidence-based multi-source research methodology combining primary clinical interviews, regulatory review, and supplier analysis to validate strategic insights
This analysis integrates a multi-source qualitative and quantitative research approach designed to capture technological trends, supply chain impacts, and clinical adoption patterns. Primary research included in-depth interviews with clinical leaders, procurement executives, service operations managers, and device engineers to surface frontline perspectives on platform performance, training needs, and maintenance realities. Secondary research involved reviewing peer-reviewed clinical literature, regulatory guidance documents, and public company disclosures to validate technology trajectories and service models.
Triangulation methods were applied to reconcile discrepancies between manufacturer claims, clinical feedback, and logistics realities, with particular attention to regional regulatory differences and tariff-driven supply chain adjustments. The synthesis emphasized evidence-based insights over speculative projections, and findings were iteratively validated with subject-matter experts to ensure relevance for decision-makers evaluating product roadmaps, procurement strategies, and partnership opportunities.
A concise synthesis of how technology, services, and supply chain resilience together determine long-term adoption and value capture in surgical robotics
Robotic-assisted surgery systems stand at a crossroads where technological maturity, expanding clinical breadth, and service innovation converge to reshape surgical care delivery. The interplay of modular system design, instrument diversity, and digitally enabled services offers a pathway to improved workflow efficiency and clinical outcomes, provided that vendors and health systems coordinate on training, maintenance, and interoperability standards. At the same time, external factors such as tariff policies and regional manufacturing strategies are introducing new considerations that affect procurement cadence and aftermarket economics.
Looking ahead, stakeholders that emphasize integrated platform ecosystems, resilient supply chains, and strong service footprints will be best positioned to capture durable adoption across hospitals, specialty clinics, and ambulatory surgical centers. By aligning product development with clinical needs and operational realities, companies can accelerate meaningful improvements in procedural efficiency and patient care delivery while creating sustainable business models that support long-term growth.
Note: PDF & Excel + Online Access - 1 Year
A concise orientation to how technological maturation, clinical validation, and service ecosystems are driving strategic adoption of robotic-assisted surgical platforms
Robotic-assisted surgery systems have evolved from a nascent surgical aid into a platform technology reshaping clinical pathways across multiple surgical specialties. Over the past decade, technological refinements in robotic arms, endoscopic visualization, and instrument ergonomics have converged with expanding clinical evidence to drive broader adoption among hospitals, specialty clinics, and ambulatory surgical centers. As a result, stakeholder expectations have shifted from proof-of-concept demonstrations toward demonstrated improvements in workflow efficiency, perioperative outcomes, and patient throughput.
Consequently, the competitive dynamic now favors integrated solutions that combine flexible hardware architectures with modular instruments and a clear services strategy encompassing training and maintenance. Investors and healthcare executives are increasingly focused on interoperability with digital health records, analytics-enabled performance monitoring, and scalable service models that reduce total cost of ownership. With these forces in play, strategic decision-makers must balance capital deployment, clinical validation timelines, and long-term service commitments when evaluating robotic platforms for acquisition or partnership.
How modular hardware, expanding clinical applications, and data-driven service models are collectively reshaping vendor differentiation and hospital adoption dynamics
The landscape of robotic-assisted surgery is experiencing transformative shifts driven by three interrelated trends: platform modularity, therapeutic breadth expansion, and digitally enabled services. First, modular hardware architectures and instrument standardization are reducing entry barriers for hospitals and clinics by offering more configurable systems that can be tailored to specialty-specific workflows, thereby enhancing affordability and clinical fit. Second, the clinical application set is expanding beyond early adopters in urology and gynecology into complex domains such as thoracic procedures and orthopedics, reflecting a maturation of surgeon experience and evidence supporting procedural benefits.
Third, the integration of data-driven services-ranging from remote proctoring and training to predictive maintenance-has redefined vendor-customer relationships. These services not only enhance uptime and clinical confidence but also create recurring revenue streams that align vendor incentives with clinical outcomes. Taken together, these shifts are accelerating platform differentiation through software-enabled capabilities and creating a new emphasis on surgical ecosystems where instruments, services, and systems co-evolve to meet institutional priorities.
Practical implications of 2025 tariff measures on sourcing strategies, service logistics, and the total cost dynamics of robotic-assisted surgery platforms
Recent tariff policies introduced in 2025 have introduced an additional operating consideration for supply chain planners, procurement teams, and strategic sourcing functions across the surgical robotics value chain. Import duties on certain imported components and finished platforms have altered the relative economics of sourcing, prompting some suppliers to re-evaluate vendor relationships and to consider nearshoring or regional manufacturing to mitigate exposure. As a direct consequence, procurement cycles now incorporate tariff risk assessments alongside quality and delivery metrics, and contract terms increasingly reflect clauses to address levy changes and currency volatility.
Importantly, the cumulative impact of the tariffs extends beyond unit procurement costs to influence after-sales service logistics and spare-parts pricing. Providers that previously relied on centralized spares hubs may now face longer lead times or higher landed costs for replacement instruments and corrective maintenance activities. In response, several system manufacturers and large hospital networks are exploring alternative strategies, including establishing regional parts inventories, increasing preventive maintenance capabilities to reduce corrective interventions, and negotiating longer-term service agreements to stabilize total cost of ownership. These adaptive measures are reshaping supplier selection criteria and strategic partnerships within the ecosystem.
Segment-specific strategic implications across components, applications, and end-user environments that determine procurement drivers and service priorities
A nuanced understanding of segmentation reveals where clinical demand and commercial opportunity intersect across components, applications, and end-user settings. From a components perspective, the market comprises systems, instruments and accessories, and services; systems now offer choices between single-arm and multi-arm robotic architectures, while instruments and accessories span endoscopic, stapling, and suturing categories, with endoscopic instruments further differentiated into graspers and scissors. The services layer encompasses consultancy, training and education, and maintenance, with maintenance services divided into preventive and corrective modalities, each influencing uptime and lifecycle economics. Together, these component-level distinctions determine purchase rationales, upgrade pathways, and aftermarket revenue potential.
When viewed through the lens of clinical applications, adoption patterns vary across cardiothoracic, ENT, general surgery, gynecology, neurosurgery, orthopedic, and urology procedures, with specialty-specific instrumentation and visualization requirements shaping both capital procurement and consumable replacement rhythms. Simultaneously, the end-user context-whether ambulatory surgical centers, hospitals, or specialty clinics-affects procurement cycles, capital approval processes, and service expectations, since ambulatory settings typically prioritize throughput and cost efficiency whereas tertiary hospitals may emphasize advanced capabilities and training partnerships. Integrating these segmentation dimensions enables more precise targeting of product roadmaps, pricing strategies, and service offerings that align with how different customers deploy and sustain robotic-assisted surgery systems.
How diverse regional regulatory environments, reimbursement landscapes, and manufacturing ecosystems are shaping adoption pathways and commercial strategies globally
Regional dynamics continue to exert a profound influence on clinical adoption, regulatory pathways, and manufacturing strategies. In the Americas, regulatory clarity, reimbursement mechanisms, and strong hospital networks support continued investments in advanced surgical platforms, while supply chain shifts following policy changes are prompting localized sourcing and inventory strategies. Europe, Middle East & Africa presents a heterogeneous picture in which advanced healthcare centers in western Europe drive demand for sophisticated multi-arm platforms and integrated service agreements, whereas markets in other parts of the region prioritize cost-effective systems, targeted training programs, and scalable maintenance solutions to extend clinical reach.
The Asia-Pacific region is characterized by rapid uptake in high-volume surgical centers, growing domestic manufacturing capabilities, and proactive investments in training and infrastructure. Consequently, vendors pursuing a global footprint must adapt commercialization models to regional requirements, balancing centralized engineering excellence with distributed manufacturing and localized service delivery. In each geography, regulatory nuance, reimbursement frameworks, and the structure of hospital procurement processes will continue to shape both adoption velocity and the evolution of partnerships between system providers and healthcare institutions.
Why competitive advantage is shifting from hardware alone to integrated platform ecosystems combining instruments, software, and comprehensive service capabilities
Competitive dynamics in robotic-assisted surgery systems are moving beyond hardware performance to emphasize platform ecosystems that combine durable systems, interoperable instruments, and robust service portfolios. Leading players are investing in instrument modularity, improved haptic feedback, enhanced visualization, and software features that facilitate workflow standardization and analytics-driven performance improvement. Meanwhile, newer entrants are differentiating on price-to-performance ratios, targeted specialty offerings, and partnerships with device suppliers to accelerate instrument availability for niche procedures.
Furthermore, the aftermarket services dimension has emerged as a critical competitive battleground. Firms that can deliver comprehensive training programs, rapid corrective maintenance, and predictive servicing capabilities gain a strategic advantage by increasing customer retention and creating recurring revenue opportunities. Alliances between platform vendors and third-party service providers are becoming more common as companies seek to expand geographic coverage and reduce response times. Ultimately, successful companies will be those that can align clinical evidence, commercial agility, and service excellence to meet the evolving expectations of hospital administrators and surgical teams.
Practical strategic moves for vendors and health systems to capture value through modular design, resilient supply chains, and service-led differentiation
Industry leaders should prioritize a set of actionable initiatives to maintain momentum and capture value as the market evolves. First, invest in modular platform designs that allow for specialty-specific instrument attachments and upgrades without requiring full system replacement, thereby protecting institutional capital investments and enabling phased adoption across departments. Second, develop scalable service models that balance preventive maintenance with remote diagnostics and predictive analytics, reducing downtime while creating recurring revenue streams that align vendor and customer incentives.
Third, strengthen regional manufacturing and parts distribution capabilities to mitigate tariff and logistics risks, while cultivating training partnerships with leading clinical centers to accelerate surgeon proficiency and procedural adoption. Fourth, pursue interoperability and data integration standards that allow platforms to contribute to broader hospital digital strategies, improving clinical workflows and enabling outcome measurement. By implementing these priorities in parallel, organizations can improve customer retention, reduce operational friction, and position their offerings for sustained institutional adoption.
An evidence-based multi-source research methodology combining primary clinical interviews, regulatory review, and supplier analysis to validate strategic insights
This analysis integrates a multi-source qualitative and quantitative research approach designed to capture technological trends, supply chain impacts, and clinical adoption patterns. Primary research included in-depth interviews with clinical leaders, procurement executives, service operations managers, and device engineers to surface frontline perspectives on platform performance, training needs, and maintenance realities. Secondary research involved reviewing peer-reviewed clinical literature, regulatory guidance documents, and public company disclosures to validate technology trajectories and service models.
Triangulation methods were applied to reconcile discrepancies between manufacturer claims, clinical feedback, and logistics realities, with particular attention to regional regulatory differences and tariff-driven supply chain adjustments. The synthesis emphasized evidence-based insights over speculative projections, and findings were iteratively validated with subject-matter experts to ensure relevance for decision-makers evaluating product roadmaps, procurement strategies, and partnership opportunities.
A concise synthesis of how technology, services, and supply chain resilience together determine long-term adoption and value capture in surgical robotics
Robotic-assisted surgery systems stand at a crossroads where technological maturity, expanding clinical breadth, and service innovation converge to reshape surgical care delivery. The interplay of modular system design, instrument diversity, and digitally enabled services offers a pathway to improved workflow efficiency and clinical outcomes, provided that vendors and health systems coordinate on training, maintenance, and interoperability standards. At the same time, external factors such as tariff policies and regional manufacturing strategies are introducing new considerations that affect procurement cadence and aftermarket economics.
Looking ahead, stakeholders that emphasize integrated platform ecosystems, resilient supply chains, and strong service footprints will be best positioned to capture durable adoption across hospitals, specialty clinics, and ambulatory surgical centers. By aligning product development with clinical needs and operational realities, companies can accelerate meaningful improvements in procedural efficiency and patient care delivery while creating sustainable business models that support long-term growth.
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
199 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency
- 1.5. Language
- 1.6. Stakeholders
- 2. Research Methodology
- 3. Executive Summary
- 4. Market Overview
- 5. Market Insights
- 5.1. Integration of artificial intelligence algorithms for real-time guidance and enhanced precision in robotic-assisted surgery systems
- 5.2. Development of haptic feedback technologies to improve tactile sensation for surgeons operating robotic platforms
- 5.3. Emergence of compact and mobile robotic surgery units enabling procedures in outpatient and rural healthcare settings
- 5.4. Growing adoption of cloud-connected robotic systems for remote monitoring, diagnostics, and software updates
- 5.5. Expansion of single-port and multi-quadrant robotic platforms to address diverse minimally invasive surgical procedures
- 5.6. Increasing collaborations between device manufacturers and academic institutions to accelerate clinical validation of robotic-assisted surgery systems
- 5.7. Advancements in autonomous suturing and tissue manipulation capabilities to reduce surgeon workload during complex procedures
- 5.8. Rising investments in end-to-end robotic-assisted orthopedic and spinal surgery solutions for improved patient outcomes
- 5.9. Regulatory approvals and reimbursement policy changes driving broader adoption of robotic-assisted surgical technologies
- 6. Cumulative Impact of United States Tariffs 2025
- 7. Cumulative Impact of Artificial Intelligence 2025
- 8. Robotic-assisted Surgery Systems Market, by Components
- 8.1. Instruments & Accessories
- 8.1.1. Endoscopic Instruments
- 8.1.1.1. Graspers
- 8.1.1.2. Scissors
- 8.1.2. Stapling Instruments
- 8.1.3. Suturing Instruments
- 8.2. Services
- 8.2.1. Consultancy Services
- 8.2.2. Maintenance Services
- 8.2.2.1. Corrective Maintenance
- 8.2.2.2. Preventive Maintenance
- 8.2.3. Training & Education
- 8.3. Systems
- 8.3.1. Multi-Arm Robotic
- 8.3.2. Single-Arm Robotic
- 9. Robotic-assisted Surgery Systems Market, by Applications
- 9.1. Cardiothoracic
- 9.2. ENT
- 9.3. General Surgery
- 9.4. Gynecology
- 9.5. Neurosurgery
- 9.6. Orthopedic
- 9.7. Urology
- 10. Robotic-assisted Surgery Systems Market, by End Users
- 10.1. Ambulatory Surgical Centers
- 10.2. Hospitals
- 10.3. Specialty Clinics
- 11. Robotic-assisted Surgery Systems Market, by Region
- 11.1. Americas
- 11.1.1. North America
- 11.1.2. Latin America
- 11.2. Europe, Middle East & Africa
- 11.2.1. Europe
- 11.2.2. Middle East
- 11.2.3. Africa
- 11.3. Asia-Pacific
- 12. Robotic-assisted Surgery Systems Market, by Group
- 12.1. ASEAN
- 12.2. GCC
- 12.3. European Union
- 12.4. BRICS
- 12.5. G7
- 12.6. NATO
- 13. Robotic-assisted Surgery Systems Market, by Country
- 13.1. United States
- 13.2. Canada
- 13.3. Mexico
- 13.4. Brazil
- 13.5. United Kingdom
- 13.6. Germany
- 13.7. France
- 13.8. Russia
- 13.9. Italy
- 13.10. Spain
- 13.11. China
- 13.12. India
- 13.13. Japan
- 13.14. Australia
- 13.15. South Korea
- 14. Competitive Landscape
- 14.1. Market Share Analysis, 2024
- 14.2. FPNV Positioning Matrix, 2024
- 14.3. Competitive Analysis
- 14.3.1. Intuitive Surgical, Inc.
- 14.3.2. Stryker Corporation
- 14.3.3. Medtronic plc
- 14.3.4. Zimmer Biomet Holdings, Inc.
- 14.3.5. Johnson & Johnson
- 14.3.6. Smith & Nephew plc
- 14.3.7. Asensus Surgical, Inc.
- 14.3.8. CMR Surgical Ltd
- 14.3.9. Renishaw plc
- 14.3.10. Titan Medical Inc.
- 14.3.11. Globus Medical, Inc.
- 14.3.12. Accuray Incorporated
- 14.3.13. PROCEPT BioRobotics Corporation
- 14.3.14. Siemens Healthineers AG
- 14.3.15. Brainlab SE
- 14.3.16. Shanghai MicroPort MedBot (Group) Co., Ltd.
- 14.3.17. meerecompany Inc.
- 14.3.18. Stereotaxis, Inc.
- 14.3.19. THINK Surgical, Inc.
- 14.3.20. Medicaroid Corporation
- 14.3.21. TINAVI Medical Technologies Co., Ltd.
- 14.3.22. Neocis Inc.
- 14.3.23. Shandong WEGO Surgery Robot Co., Ltd.
- 14.3.24. Shenzhen Futurtec Medical Co., Ltd.
- 14.3.25. Distalmotion SA
- 14.3.26. avateramedical GmbH
- 14.3.27. Vicarious Surgical Inc.
- 14.3.28. SRI International
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
